Table 3.
All deaths | On OAT | Off | |
---|---|---|---|
Cardiovascular | 3 | 3 | 0 |
Cancer − not liver | 7 | 6 | 1 |
Liver including liver cancer | 5 | 4 | 1 |
Bacterial infections | 3 | 2 | 1 |
Resp. disease | 4 | 4 | 0 |
Somatic causes − total | 22 (53.7) | 19 | 3 |
Drug-induced cause (overdoses/SUD) | 11 (26.8) | 7 | 4 |
Suicide | 2 | 1 | 1 |
Unintentional accidents | 1 | 1 | 0 |
Homicide | 3 | 3 | 0 |
Traumatic causes − total | 6 (14.6) | 5 | 1 |
Unknown cause1 | 2 (4.9) | 2 | 0 |
All | 41 (100) | 33 | 8 |
Values are numbers with percentages in parentheses. 2,109 patients-years (PY) on OAT, 221 PY off OAT, 112 PY unknown OAT status2. N = 195 (cohort in the 2016 follow-up study3).
1Both deaths were sudden deaths without certain cause.
2No deaths occurred in the period with unknown OAT status.
3The original cohort comprised 200 participants who had started OMT as of 1 January 1998 until 30 June 2007 (13 had died before the cohort was established in 2008), 5 persons declined to participate in the 2016 follow-up study.